In addition to lung cancer, high EZH2 protein expression has been observed in several other malignant tumors, such as gastric cancer, pancreatic cancer and its expression has been reportedly correlated with poor survival in these patients [10–14, 58]. This evidence concerns the gene EZH2 and familial pancreatic carcinoma.